New Colorado Law Prohibits Sale of OTC Cough Medicine to Minors

WASHINGTON, D.C.–(BUSINESS WIRE)–The Consumer Healthcare Products Association (CHPA) applauds Colorado
for enacting a law prohibiting the sale of over-the-counter (OTC)
medicines containing the cough suppressant dextromethorphan (DXM) to
minors this week. HB 1307 was signed into law by Colorado Governor John
Hickenlooper on May 11, 2018.

While millions of Americans use products containing DXM to safely treat
their symptoms, according to the 2017 National Institute on Drug Abuse
(NIDA) annual Monitoring
the Future survey
, one in 30 teens abuses
OTC cough medicine containing DXM to get high

“Colorado is the 16th state to pass an age-18 sales law,
joining states across the country in recognizing that limiting teen
access to DXM is a proven way to prevent abuse,” said CHPA President and
CEO Scott Melville. “This is a common-sense law, that restricts access
to teens who may abuse these products, while maintaining access for the
millions of Americans who use them responsibly. Committed Colorado state
lawmakers have been crucial allies in our abuse prevention efforts, and
we thank them for their hard work.”

CHPA has long supported national educational efforts to curb teen OTC
cough medicine abuse through its education
campaign, which includes collaborations with The Partnership for
Drug-Free Kids and Community Anti-Drug Coalitions of America (CADCA).

Recognizing that retailers play a critical role in abuse prevention,
last year, CHPA announced a new initiative to support retailers in
states that have adopted laws prohibiting the sale OTC cough medicine
containing DXM to minors. Retailers can download
or order
free materials on the Stop Medicine Abuse website.

For more information about teen DXM abuse and other helpful resources
for parents and community leaders, please visit

The Consumer Healthcare Products Association (CHPA) is the
137-year-old national trade association representing the leading
manufacturers and marketers of over-the-counter (OTC) medicines and
dietary supplements. Every dollar spent by consumers on OTC medicines
saves the U.S. healthcare system $6-$7, contributing a total of $102
billion in savings each year. CHPA is committed to empowering self-care
by preserving and expanding choice and availability of consumer
healthcare products.


Consumer Healthcare Products Association (CHPA)
Lauren Bloomberg,